Follicular lymphoma grade I, unspecified site
ICD-10 C82.00 is a billable code used to indicate a diagnosis of follicular lymphoma grade i, unspecified site.
Follicular lymphoma grade I is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. It is typically indolent, meaning it progresses slowly, and is often diagnosed incidentally during imaging or biopsy for other reasons. The 'grade I' designation indicates a low proliferation rate, which correlates with a better prognosis compared to higher-grade lymphomas. Patients may present with lymphadenopathy, splenomegaly, or asymptomatic findings. The disease can be staged using the Ann Arbor system, which considers the number of lymph node regions involved and the presence of systemic symptoms. B-symptoms, including fever, night sweats, and weight loss, may occur but are less common in grade I cases. Treatment options vary based on the stage and symptoms, ranging from active surveillance in asymptomatic patients to chemotherapy, immunotherapy, or radiation therapy for symptomatic cases. Regular follow-up is essential to monitor for disease progression.
Detailed clinical notes on staging, treatment plans, and follow-up assessments.
Diagnosis of lymphoma during routine check-ups, management of treatment side effects, and follow-up for disease progression.
Ensure accurate grading and staging are documented to support treatment decisions.
Histopathological reports detailing the grade and subtype of lymphoma.
Biopsy results indicating follicular lymphoma, grading of lymphoma specimens.
Clear communication of findings to the treating physician is crucial for accurate coding.
Used when a patient with follicular lymphoma grade I requires treatment.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy sessions.
Follicular lymphoma grade I generally has a favorable prognosis, with many patients living for years without significant symptoms. However, individual outcomes can vary based on factors such as age, overall health, and response to treatment.
